|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 791 for Fasl

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.105s

Categories

Category: Publication
« show all
Type Details Score
Publication
7826947 | J:21325
First Author: Takahashi T
Year: 1994
Journal: Int Immunol
Title: Human Fas ligand: gene structure, chromosomal location and species specificity.
Volume: 6
Issue: 10
Pages: 1567-74
•
•
•
•
•
Publication
11741599 | J:73329
First Author: Wenzel J
Year: 2001
Journal: FEBS Lett
Title: Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor.
Volume: 509
Issue: 2
Pages: 255-62
•
•
•
•
•
Publication
17557115 | -
First Author: Kirkin V
Year: 2007
Journal: Cell Death Differ
Title: The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells.
Volume: 14
Issue: 9
Pages: 1678-87
•
•
•
•
•
Publication
11391000 | -
First Author: Yankee TM
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling.
Volume: 98
Issue: 12
Pages: 6789-93
•
•
•
•
•
Publication
30283358 | J:314318
 
First Author: Svandova E
Year: 2018
Journal: Front Physiol
Title: FasL Modulates Expression of Mmp2 in Osteoblasts.
Volume: 9
Pages: 1314
•
•
•
•
•
Publication
8579749 | J:29893
First Author: Lynch DH
Year: 1995
Journal: Immunol Today
Title: Fas and FasL in the homeostatic regulation of immune responses.
Volume: 16
Issue: 12
Pages: 569-74
•
•
•
•
•
Publication
31582729 | J:293321
First Author: Tan S
Year: 2019
Journal: Cell Death Dis
Title: IL-6-driven FasL promotes NF-κBp65/PUMA-mediated apoptosis in portal hypertensive gastropathy.
Volume: 10
Issue: 10
Pages: 748
•
•
•
•
•
Publication
12512872 | J:81060
First Author: Embree-Ku M
Year: 2002
Journal: Toxicol Pathol
Title: FasL deficiency enhances the development of tumors in p53+/- mice.
Volume: 30
Issue: 6
Pages: 705-13
•
•
•
•
•
Publication
37013690 | J:342672
First Author: Bernard-Bloch R
Year: 2023
Journal: J Leukoc Biol
Title: Ambivalent role of FasL in murine acute graft-versus-host-disease.
Volume: 114
Issue: 3
Pages: 205-211
•
•
•
•
•
Publication
34135904 | J:337299
 
First Author: Apaza Alccayhuaman KA
Year: 2021
Journal: Front Immunol
Title: FasL Is Required for Osseous Healing in Extraction Sockets in Mice.
Volume: 12
Pages: 678873
•
•
•
•
•
Publication
17675495 | J:151220
First Author: He JS
Year: 2007
Journal: J Immunol
Title: CTLs contain and use intracellular stores of FasL distinct from cytolytic granules.
Volume: 179
Issue: 4
Pages: 2339-48
•
•
•
•
•
Publication
16807368 | J:111341
First Author: Semkova I
Year: 2006
Journal: FASEB J
Title: Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
Volume: 20
Issue: 10
Pages: 1689-91
•
•
•
•
•
Publication
8658177 | J:34061
First Author: Lau HT
Year: 1996
Journal: Science
Title: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.
Volume: 273
Issue: 5271
Pages: 109-12
•
•
•
•
•
Publication
16710360 | J:132253
First Author: Wang X
Year: 2006
Journal: Cell Death Differ
Title: Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress.
Volume: 13
Issue: 12
Pages: 2099-108
•
•
•
•
•
Publication
16935260 | J:112563
First Author: Wang CC
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Mouse lymphomas caused by an intron-splicing donor site deletion of the FasL gene.
Volume: 349
Issue: 1
Pages: 50-8
•
•
•
•
•
Publication
17290285 | J:139274
First Author: Schulte M
Year: 2007
Journal: Cell Death Differ
Title: ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
Volume: 14
Issue: 5
Pages: 1040-9
•
•
•
•
•
Publication
23408968 | J:197206
First Author: Fujikura D
Year: 2013
Journal: PLoS One
Title: Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza.
Volume: 8
Issue: 2
Pages: e55321
•
•
•
•
•
Publication
24667392 | J:215056
First Author: Sato A
Year: 2014
Journal: PLoS One
Title: Involvement of the TNF and FasL produced by CD11b Kupffer cells/macrophages in CCl4-induced acute hepatic injury.
Volume: 9
Issue: 3
Pages: e92515
•
•
•
•
•
Publication
25361085 | J:258532
First Author: O'Reilly LA
Year: 2015
Journal: Cell Death Differ
Title: Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.
Volume: 22
Issue: 5
Pages: 767-78
•
•
•
•
•
Publication
18676775 | J:157436
First Author: Cohen PY
Year: 2009
Journal: Am J Respir Cell Mol Biol
Title: Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases.
Volume: 40
Issue: 2
Pages: 231-8
•
•
•
•
•
Publication
12094020 | J:103281
First Author: Embree-Ku M
Year: 2002
Journal: Exp Biol Med (Maywood)
Title: Absence of p53 and FasL has sexually dimorphic effects on both development and reproduction.
Volume: 227
Issue: 7
Pages: 545-53
•
•
•
•
•
Publication
17192273 | J:120868
First Author: Yao PL
Year: 2007
Journal: J Biol Chem
Title: Transcriptional regulation of FasL expression and participation of sTNF-alpha in response to sertoli cell injury.
Volume: 282
Issue: 8
Pages: 5420-31
•
•
•
•
•
Publication
16356862 | J:113311
First Author: Legge KL
Year: 2005
Journal: Immunity
Title: Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression.
Volume: 23
Issue: 6
Pages: 649-59
•
•
•
•
•
Publication
26494122 | J:227269
First Author: Shanker A
Year: 2015
Journal: Cancer Res
Title: Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.
Volume: 75
Issue: 24
Pages: 5260-72
•
•
•
•
•
Publication
20405474 | J:161865
First Author: Gorbachev AV
Year: 2010
Journal: Eur J Immunol
Title: CD4+CD25+ regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses.
Volume: 40
Issue: 7
Pages: 2006-15
•
•
•
•
•
Publication
17591957 | J:122835
First Author: Mohamood AS
Year: 2007
Journal: Am J Pathol
Title: Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
Volume: 171
Issue: 1
Pages: 97-106
•
•
•
•
•
Publication
20100735 | J:158533
First Author: Lin YC
Year: 2010
Journal: Toxicol Sci
Title: FasL gene-deficient mice display a limited disruption in spermatogenesis and inhibition of mono-(2-ethylhexyl) phthalate-induced germ cell apoptosis.
Volume: 114
Issue: 2
Pages: 335-45
•
•
•
•
•
Publication
11292588 | J:69305
First Author: Chung CS
Year: 2001
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated.
Volume: 280
Issue: 5
Pages: G812-8
•
•
•
•
•
Publication
31038471 | J:289200
First Author: Hornick EE
Year: 2019
Journal: J Clin Invest
Title: Dendritic cell NLRC4 regulates influenza A virus-specific CD4 T cell responses through FasL expression.
Volume: 129
Issue: 7
Pages: 2888-2897
•
•
•
•
•
Publication
26967483 | J:319158
First Author: Schmidt M
Year: 2016
Journal: J Invest Dermatol
Title: Thy-1/β3 Integrin Interaction-Induced Apoptosis of Dermal Fibroblasts Is Mediated by Up-Regulation of FasL Expression.
Volume: 136
Issue: 2
Pages: 526-529
•
•
•
•
•
Publication
20889682 | J:166543
First Author: Villa-Morales M
Year: 2010
Journal: Carcinogenesis
Title: Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.
Volume: 31
Issue: 12
Pages: 2165-71
•
•
•
•
•
Publication
29940333 | J:325837
 
First Author: Soloviova K
Year: 2018
Journal: Clin Immunol
Title: Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.
Volume: 194
Pages: 34-42
•
•
•
•
•
Publication
7533326 | J:23794
First Author: Nagata S
Year: 1995
Journal: Science
Title: The Fas death factor.
Volume: 267
Issue: 5203
Pages: 1449-56
•
•
•
•
•
Publication
10898516 | J:62735
First Author: Zhu B
Year: 2000
Journal: Eur J Immunol
Title: Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody.
Volume: 30
Issue: 6
Pages: 1778-84
•
•
•
•
•
Publication
7511063 | J:17445
First Author: Takahashi T
Year: 1994
Journal: Cell
Title: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Volume: 76
Issue: 6
Pages: 969-76
•
•
•
•
•
Publication
7495745 | J:28840
First Author: Hahne M
Year: 1995
Journal: Int Immunol
Title: Characterization of the non-functional Fas ligand of gld mice.
Volume: 7
Issue: 9
Pages: 1381-6
•
•
•
•
•
Publication
9317104 | J:43096
First Author: Waldner H
Year: 1997
Journal: J Immunol
Title: Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis.
Volume: 159
Issue: 7
Pages: 3100-3
•
•
•
•
•
Publication
21479271 | J:171440
First Author: Gregory MS
Year: 2011
Journal: PLoS One
Title: Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.
Volume: 6
Issue: 3
Pages: e17659
•
•
•
•
•
Publication
15265879 | J:92022
First Author: Barreiro R
Year: 2004
Journal: J Immunol
Title: Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.
Volume: 173
Issue: 3
Pages: 1519-25
•
•
•
•
•
Publication
28094869 | J:272131
First Author: Potter CS
Year: 2017
Journal: Exp Dermatol
Title: Loss of FAS/FASL signalling does not reduce apoptosis in Sharpin null mice.
Volume: 26
Issue: 9
Pages: 820-822
•
•
•
•
•
Publication
10352252 | J:110922
First Author: Dittel BN
Year: 1999
Journal: J Immunol
Title: Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis.
Volume: 162
Issue: 11
Pages: 6392-400
•
•
•
•
•
Publication
27573825 | J:235578
First Author: Kong S
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas.
Volume: 113
Issue: 37
Pages: 10394-9
•
•
•
•
•
Publication
10086384 | J:53306
First Author: Kaplan HJ
Year: 1999
Journal: Nat Med
Title: Fas ligand (CD95 ligand) controls angiogenesis beneath the retina.
Volume: 5
Issue: 3
Pages: 292-7
•
•
•
•
•
Publication
17049562 | J:129276
First Author: Petri S
Year: 2006
Journal: J Neurol Sci
Title: Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.
Volume: 251
Issue: 1-2
Pages: 44-9
•
•
•
•
•
Publication
10900166 | J:102662
First Author: Sata M
Year: 2000
Journal: J Mol Cell Cardiol
Title: Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels.
Volume: 32
Issue: 8
Pages: 1395-400
•
•
•
•
•
Publication
27798616 | J:260264
First Author: Hägglöf T
Year: 2016
Journal: Nat Immunol
Title: Neutrophils license iNKT cells to regulate self-reactive mouse B cell responses.
Volume: 17
Issue: 12
Pages: 1407-1414
•
•
•
•
•
Publication
8643610 | J:78762
First Author: Weih F
Year: 1996
Journal: Proc Natl Acad Sci U S A
Title: Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.
Volume: 93
Issue: 11
Pages: 5533-8
•
•
•
•
•
Publication
11956070 | J:134937
First Author: Couillard M
Year: 2002
Journal: Cancer Res
Title: c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction.
Volume: 62
Issue: 8
Pages: 2210-4
•
•
•
•
•
Publication
20220091 | J:160053
First Author: Langlois RA
Year: 2010
Journal: J Immunol
Title: Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
Volume: 184
Issue: 8
Pages: 4440-6
•
•
•
•
•
Publication
8605944 | J:32020
First Author: Hahne M
Year: 1996
Journal: Eur J Immunol
Title: Activated B cells express functional Fas ligand.
Volume: 26
Issue: 3
Pages: 721-4
•
•
•
•
•
Publication
12045257 | J:76811
First Author: Crawford HC
Year: 2002
Journal: J Clin Invest
Title: Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Volume: 109
Issue: 11
Pages: 1437-44
•
•
•
•
•
Publication
9502590 | J:45783
First Author: Hoek RM
Year: 1997
Journal: J Immunol Methods
Title: Allele-specific PCR analysis for detection of the gld Fas-ligand point mutation.
Volume: 210
Issue: 1
Pages: 109-12
•
•
•
•
•
Publication
14764677 | J:87990
First Author: Karray S
Year: 2004
Journal: J Immunol
Title: Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele.
Volume: 172
Issue: 4
Pages: 2118-25
•
•
•
•
•
Publication
10514014 | J:57879
First Author: Tsutsui H
Year: 1999
Journal: Immunity
Title: Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.
Volume: 11
Issue: 3
Pages: 359-67
•
•
•
•
•
Publication
24012421 | J:208212
First Author: Figgett WA
Year: 2013
Journal: Immunity
Title: The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.
Volume: 39
Issue: 3
Pages: 573-83
•
•
•
•
•
Publication
35008734 | J:317688
 
First Author: Mustafa N
Year: 2021
Journal: Int J Mol Sci
Title: E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Volume: 23
Issue: 1
•
•
•
•
•
Publication
19013083 | J:142793
First Author: Mabrouk I
Year: 2008
Journal: Immunity
Title: Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
Volume: 29
Issue: 6
Pages: 922-33
•
•
•
•
•
Publication
17716913 | J:126752
First Author: Hill RA
Year: 2007
Journal: Mol Cell Neurosci
Title: Fas/FasL-mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective estrogen receptor alpha and estrogen receptor beta agonist treatment, respectively.
Volume: 36
Issue: 2
Pages: 146-57
•
•
•
•
•
Publication
21593251 | J:196045
First Author: Huang X
Year: 2011
Journal: J Dent Res
Title: Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis.
Volume: 90
Issue: 8
Pages: 981-7
•
•
•
•
•
Publication
15895074 | J:99349
First Author: Jonsson H
Year: 2005
Journal: Nat Med
Title: Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis.
Volume: 11
Issue: 6
Pages: 666-71
•
•
•
•
•
Publication
9391118 | J:44640
First Author: Arai H
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Gene transfer of Fas ligand induces tumor regression in vivo.
Volume: 94
Issue: 25
Pages: 13862-7
•
•
•
•
•
Publication
9759866 | J:49846
First Author: Matsui K
Year: 1998
Journal: J Immunol
Title: Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Volume: 161
Issue: 7
Pages: 3469-73
•
•
•
•
•
Publication
9846492 | J:51334
First Author: Bonfoco E
Year: 1998
Journal: Immunity
Title: Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells.
Volume: 9
Issue: 5
Pages: 711-20
•
•
•
•
•
Publication
15470053 | J:93704
First Author: Xiao S
Year: 2004
Journal: J Immunol
Title: Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: evidence for translational regulation and against Fas ligand retention in secretory lysosomes.
Volume: 173
Issue: 8
Pages: 5095-102
•
•
•
•
•
Publication
16849454 | J:138030
First Author: Sun M
Year: 2006
Journal: J Immunol
Title: The cytoplasmic domain of Fas ligand costimulates TCR signals.
Volume: 177
Issue: 3
Pages: 1481-91
•
•
•
•
•
Publication
21517838 | J:172801
First Author: Hassin D
Year: 2011
Journal: Immunology
Title: Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.
Volume: 133
Issue: 2
Pages: 190-6
•
•
•
•
•
Publication
16339539 | J:122239
First Author: Kidoya H
Year: 2005
Journal: J Immunol
Title: Fas ligand induces cell-autonomous IL-23 production in dendritic cells, a mechanism for Fas ligand-induced IL-17 production.
Volume: 175
Issue: 12
Pages: 8024-31
•
•
•
•
•
Publication
17545588 | J:122193
First Author: Villa-Morales M
Year: 2007
Journal: Cancer Res
Title: A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.
Volume: 67
Issue: 11
Pages: 5107-16
•
•
•
•
•
Publication
7889405 | J:21065
First Author: Lynch DH
Year: 1994
Journal: Immunity
Title: The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.
Volume: 1
Issue: 2
Pages: 131-6
•
•
•
•
•
Publication
10552956 | J:58362
First Author: Ayroldi E
Year: 1999
Journal: Blood
Title: Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Volume: 94
Issue: 10
Pages: 3456-67
•
•
•
•
•
Publication
19794494 | J:153501
First Author: O' Reilly LA
Year: 2009
Journal: Nature
Title: Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
Volume: 461
Issue: 7264
Pages: 659-63
•
•
•
•
•
Publication
9108079 | J:39809
First Author: Kayagaki N
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Polymorphism of murine Fas ligand that affects the biological activity.
Volume: 94
Issue: 8
Pages: 3914-9
•
•
•
•
•
Publication
8076595 | J:20123
First Author: Baum PR
Year: 1994
Journal: EMBO J
Title: Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
Volume: 13
Issue: 17
Pages: 3992-4001
•
•
•
•
•
Publication
17510409 | J:121728
First Author: Fingleton B
Year: 2007
Journal: Cancer Res
Title: Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
Volume: 67
Issue: 10
Pages: 4800-6
•
•
•
•
•
Publication
12482505 | J:118008
First Author: Alenzi FQ
Year: 2002
Journal: Exp Hematol
Title: A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics.
Volume: 30
Issue: 12
Pages: 1428-35
•
•
•
•
•
Publication
11441070 | J:109872
First Author: Medana I
Year: 2001
Journal: J Immunol
Title: Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Volume: 167
Issue: 2
Pages: 674-81
•
•
•
•
•
Publication
10527913 | J:59708
First Author: Kamath AB
Year: 1999
Journal: Toxicol Appl Pharmacol
Title: Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Volume: 160
Issue: 2
Pages: 141-55
•
•
•
•
•
Publication
34526992 | J:312873
 
First Author: Krzyzowska M
Year: 2021
Journal: Front Immunol
Title: Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation.
Volume: 12
Pages: 714821
•
•
•
•
•
Publication
12933876 | J:85214
First Author: Chakour R
Year: 2003
Journal: Infect Immun
Title: Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Volume: 71
Issue: 9
Pages: 5287-95
•
•
•
•
•
Publication
10049941 | J:112018
First Author: Kehren J
Year: 1999
Journal: J Exp Med
Title: Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
Volume: 189
Issue: 5
Pages: 779-86
•
•
•
•
•
Publication
9464800 | J:45139
First Author: Malipiero U
Year: 1997
Journal: Eur J Immunol
Title: Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.
Volume: 27
Issue: 12
Pages: 3151-60
•
•
•
•
•
Publication
29952767 | J:266446
First Author: Klatt C
Year: 2018
Journal: J Clin Invest
Title: Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.
Volume: 128
Issue: 9
Pages: 3906-3925
•
•
•
•
•
Publication
12358144 | J:106187
First Author: Sata M
Year: 2002
Journal: Hypertens Res
Title: Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth.
Volume: 25
Issue: 4
Pages: 577-82
•
•
•
•
•
Publication
19380712 | J:151214
First Author: Chakour R
Year: 2009
Journal: J Leukoc Biol
Title: A new function of the Fas-FasL pathway in macrophage activation.
Volume: 86
Issue: 1
Pages: 81-90
•
•
•
•
•
Publication
17675484 | J:151223
First Author: Kim SH
Year: 2007
Journal: J Immunol
Title: MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner.
Volume: 179
Issue: 4
Pages: 2235-41
•
•
•
•
•
Publication
10395644 | J:56128
First Author: Hashimoto W
Year: 1999
Journal: J Immunol
Title: Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Volume: 163
Issue: 2
Pages: 583-9
•
•
•
•
•
Publication
7528774 | J:22200
First Author: Chu JL
Year: 1995
Journal: J Exp Med
Title: Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Volume: 181
Issue: 1
Pages: 393-8
•
•
•
•
•
Publication
25604058 | J:232682
First Author: Levy O
Year: 2015
Journal: EMBO Mol Med
Title: Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration.
Volume: 7
Issue: 2
Pages: 211-26
•
•
•
•
•
Publication
23922974 | J:204362
First Author: Krzyzowska M
Year: 2013
Journal: PLoS One
Title: HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Volume: 8
Issue: 7
Pages: e70308
•
•
•
•
•
Publication
7530197 | J:22518
First Author: Watanabe D
Year: 1995
Journal: EMBO J
Title: Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Volume: 14
Issue: 1
Pages: 12-8
•
•
•
•
•
Publication
26444718 | J:231062
First Author: Rogge M
Year: 2015
Journal: Invest Ophthalmol Vis Sci
Title: Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice.
Volume: 56
Issue: 11
Pages: 6377-86
•
•
•
•
•
Publication
19654302 | J:151764
First Author: Shanker A
Year: 2009
Journal: Cancer Res
Title: Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.
Volume: 69
Issue: 16
Pages: 6615-23
•
•
•
•
•
Publication
34223817 | J:310621
   
First Author: Jeong D
Year: 2021
Journal: Elife
Title: Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.
Volume: 10
•
•
•
•
•
Publication
15148335 | J:114948
First Author: Hao Z
Year: 2004
Journal: J Exp Med
Title: T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis.
Volume: 199
Issue: 10
Pages: 1355-65
•
•
•
•
•
Publication
25873756 | J:331860
 
First Author: Bień K
Year: 2015
Journal: Mediators Inflamm
Title: Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
Volume: 2015
Pages: 281613
•
•
•
•
•
Publication
30429213 | J:271164
First Author: Xiao W
Year: 2019
Journal: Mol Cancer Res
Title: Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.
Volume: 17
Issue: 2
Pages: 420-430
•
•
•
•
•
Publication
15743781 | J:96722
First Author: Neff TA
Year: 2005
Journal: Am J Pathol
Title: Relationship of acute lung inflammatory injury to Fas/FasL system.
Volume: 166
Issue: 3
Pages: 685-94
•
•
•
•
•
Publication
19740996 | J:153977
First Author: Ishikawa T
Year: 2009
Journal: J Virol
Title: Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
Volume: 83
Issue: 22
Pages: 11777-83
•
•
•
•
•
Publication
10209037 | J:54478
First Author: Sabelko-Downes KA
Year: 1999
Journal: J Exp Med
Title: Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis.
Volume: 189
Issue: 8
Pages: 1195-205
•
•
•
•
•
Publication
10209045 | J:54480
First Author: Hill LL
Year: 1999
Journal: J Exp Med
Title: A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation.
Volume: 189
Issue: 8
Pages: 1285-94
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom